CNS Disorders  >>  Lodonal (naltrexone low dose oral) 
Welcome,         Profile    Billing    Logout  

3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lodonal (naltrexone low dose oral) / Immune Therap, Statera BioPharma
ACTRN12622000881730: Low-dose naltrexone as an adjunctive treatment in major depressive disorder.

Recruiting
4
72
 
University of Auckland, Health Research Council of New Zealand
Major depressive disorder (MDD)
 
 
2005-005679-13: An open-label, prospective, multicentric pilot study evaluating safety and symptomatics effects of low dose Naltrexone in patients with primary progressive multiple sclerosis.

Ongoing
2
40
Europe
Capsule, hard
OSPEDALE S. RAFFAELE
multiple sclerosis
 
 
NCT05536050: Study of Low-dose Naltrexone in Chronic Migraine With Fibromyalgia

Recruiting
N/A
30
US
Migraine diary and Questionnaires
Thomas Jefferson University
Chronic Migraine, Fibromyalgia, New Daily Persistent Headache
12/23
12/23

Download Options